tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics price target lowered to $10 from $30 at Mizuho
PremiumThe FlyIovance Biotherapeutics price target lowered to $10 from $30 at Mizuho
9d ago
Iovance Biotherapeutics downgraded to Hold from Buy at Truist
Premium
The Fly
Iovance Biotherapeutics downgraded to Hold from Buy at Truist
9d ago
Iovance Biotherapeutics price target lowered to $4 from $5 at Barclays
Premium
The Fly
Iovance Biotherapeutics price target lowered to $4 from $5 at Barclays
9d ago
Iovance price target lowered to $20 from $32 at H.C. Wainwright
PremiumThe FlyIovance price target lowered to $20 from $32 at H.C. Wainwright
12d ago
Iovance downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Iovance downgraded to Market Perform from Outperform at Citizens JMP
12d ago
Iovance Biotherapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Iovance Biotherapeutics Reports Q1 2025 Financial Results
12d ago
Iovance Biotherapeutics price target lowered to $5 from $22 at Barclays
PremiumThe FlyIovance Biotherapeutics price target lowered to $5 from $22 at Barclays
1M ago
Iovance Biotherapeutics price target lowered to $15 from $25 at Truist
Premium
The Fly
Iovance Biotherapeutics price target lowered to $15 from $25 at Truist
3M ago
Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
Premium
The Fly
Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100